Chronic hepatitis B virus (HBV) infection affects about 296 million people worldwide and is
the leading aetiology of cirrhosis and liver cancer globally. Major medical complications also …

Introduction Hepatocellular carcinoma (HCC) is the sixth most common cancer and the third-
leading cause of cancer-related mortality in the world. Areas covered This review will …

Summary The Asia-Pacific region is home to more than half of the global population and
accounted for 62· 6% of global deaths due to liver diseases in 2015. 54· 3% of global deaths …

Background We performed a systematic review and meta-analysis to examine factors
associated with HBV immune response in dialysis patients, and the association between the …

Vaccination against hepatitis B is the most effective strategy to control HBV infection. The
first licensed hepatitis B vaccine was developed by the purification of hepatitis B surface …

Background: Most prior studies have reported cancer mortality trends across countries for
specific cancer types. Herein, we examine recent patterns and trends in cancer mortality …

Background Determining the number of chronic hepatitis B (HBV) and C virus (HCV)
infections is essential to assess the progress towards the World Health Organization 2030 …

Methods A multinational online questionnaire survey was administered to participants at the
8th meeting of the Asian Organization for Crohn's and Colitis. The questionnaire included …

Introduction: Advancing age, comorbidity, and financial burden have been observed in
chronic hepatitis B (CHB) patients globally. As Japan is leading the world in aging …

Background Health care workers (HCWs) are frequently exposed to hepatitis B virus (HBV)
infection. The efficacy and safety of immunization with the hepatitis B (HB) vaccine are well …